Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study
- DOI
- 10.1186/s40560-023-00698-9
- Published
- 2023-11-13
- Container
- Journal of Intensive Care
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40560-023-00698-9,
title = {Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study},
author = {Matsuyuki Doi and Naoki Takahashi and Rumi Nojiri and Takehiko Hiraoka and Yusuke Kishimoto and Shinichi Inoue and Nobuyo Oya},
year = {2023},
journal = {Journal of Intensive Care},
doi = {10.1186/s40560-023-00698-9},
url = {https://doi.org/10.1186/s40560-023-00698-9}
}RIS
TY - JOUR TI - Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study AU - Matsuyuki Doi AU - Naoki Takahashi AU - Rumi Nojiri AU - Takehiko Hiraoka AU - Yusuke Kishimoto AU - Shinichi Inoue AU - Nobuyo Oya PY - 2023 JO - Journal of Intensive Care DO - 10.1186/s40560-023-00698-9 UR - https://doi.org/10.1186/s40560-023-00698-9 ER -
APA
Doi, M., Takahashi, N., Nojiri, R., Hiraoka, T., Kishimoto, Y., Inoue, S., & Oya, N. (2023). Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study. Journal of Intensive Care. https://doi.org/10.1186/s40560-023-00698-9
Source records
- crossref · retrieved 2026-09-27T08:16:19.824Z